浙江同源康医药股份有限公司（股票代码：02410，股票名称：同源康医药-B）于2026年4月2日发布3月股份变动月报表，报告期截至2026年3月31日。根据公告，公司在本月内完成4,608,000股非上市股份向H股的转换。
公告显示，该4,608,000股非上市股份于3月4日转换为H股。转换后，H股股本从上月底的375,457,818股增至380,065,818股，非上市股份则由4,608,000股降至0股。公司已发行股份总数维持380,065,818股不变，未出现股份回购、注销或新增发行。
公告同时确认，公司已符合香港联交所的公众持股量要求。公司亦未披露当月发生任何与股份期权计划、可换股债券或其他重大股权安排相关的变动。截至本月末，整体股本结构保持稳定。
该公告由执行董事、董事长兼总裁吴豫生签署。公司称将继续遵守香港联交所《上市规则》及相关法律法规的要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.